Find latest CLL videos · 100+ videos
L

Managing Cardiotoxicities in BTKi Treatment for CLL: Atrial Fibrillation and Atrial Flutter

By Lydia Scarfò 5 Videos
86 views
October 15, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Related Videos

17:12

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

1.6K views
21:28

Choosing BTKi or BCL2i or Combination Therapy for 1L CLL

Danielle Brander

312 views
26:06

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

650 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.6K views
35:12

Clinical Practice Updates in CLL/SLL

Integrity CE

M. Cortese, D. Wallace, A. Niu

351 views
05:59

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

353 views
15:19

Current Recommendations on Managing GI Adverse Reactions Associated …

Alberto Zambelli

952 views
22:29

1L Therapy in CLL: What Are the Best Options?

SOHO Brazil 2024

J. Burger

845 views
20:41

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Cleveland Clinic Taussig Cancer Institute

R. Unwala

277 views
20:13

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

233 views
14:27

Infectious Complications of Checkpoint Inhibitors: Discussing Overla…

Cleveland Clinic Taussig Cancer Institute

Z. Yetmar

217 views
21:12

3L in CLL: The Best Options in a Patient Double-Refractory to Covale…

SOHO Brazil 2024

J. Burger

502 views
15:17

Sequencing Therapies in CLL: The Importance of First-Line Treatment …

Nicole Lamanna

260 views
12:18

Debates in CLL: Continuous or Finite Duration Therapy

XV Eurasian Hematology-Oncology Congress - EHOC 2024

N. Jain

165 views
03:06

CLL Treatment Sequencing: The Importance of First Choice

City of Hope

S. Rosen

317 views
28:57

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

41 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

914 views
25:47

Practice-Changing Updates in Indolent B-Cell Lymphomas

Massachusetts General Hospital Cancer Center

J. Soumerai

465 views
18:46

ESMO 2024 Insights: Current and Future Use of EGFR-Targeted Agents i…

2024 ESMO Annual Meeting Insights Hub

P. Garrido

155 views
14:13

New

Pirtobrutinib in CLL: Current and Potential Utility in the Treatment…

Nicole Lamanna

86 views
AUTOPLAY